3,722 reports of this reaction
4.3% of all NAPROXEN SODIUM TABLET reports
#2 most reported adverse reaction
PRODUCT USE ISSUE is the #2 most commonly reported adverse reaction for NAPROXEN SODIUM TABLET, manufactured by Bayer HealthCare LLC.. There are 3,722 FDA adverse event reports linking NAPROXEN SODIUM TABLET to PRODUCT USE ISSUE. This represents approximately 4.3% of all 85,607 adverse event reports for this drug.
NAPROXEN SODIUM TABLET has an overall safety score of 78 out of 100. Patients taking NAPROXEN SODIUM TABLET who experience product use issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT USE ISSUE is moderately reported among NAPROXEN SODIUM TABLET users, representing a notable but not dominant share of adverse events.
In addition to product use issue, the following adverse reactions have been reported for NAPROXEN SODIUM TABLET:
The following drugs have also been linked to product use issue in FDA adverse event reports:
PRODUCT USE ISSUE has been reported as an adverse event in 3,722 FDA reports for NAPROXEN SODIUM TABLET. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT USE ISSUE accounts for approximately 4.3% of all adverse event reports for NAPROXEN SODIUM TABLET, making it one of the most commonly reported side effect.
If you experience product use issue while taking NAPROXEN SODIUM TABLET, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.